Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:XPOF - US98422X1019 - Common Stock

5.98 USD
+0.08 (+1.36%)
Last: 11/24/2025, 3:04:30 PM
Fundamental Rating

4

Overall XPOF gets a fundamental rating of 4 out of 10. We evaluated XPOF against 132 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on XPOF.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year XPOF was profitable.
XPOF had a positive operating cash flow in the past year.
XPOF had negative earnings in 4 of the past 5 years.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of XPOF (-15.44%) is worse than 85.61% of its industry peers.
With an excellent Return On Invested Capital value of 22.15%, XPOF belongs to the best of the industry, outperforming 93.18% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for XPOF is in line with the industry average of 10.41%.
The last Return On Invested Capital (22.15%) for XPOF is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -15.44%
ROE N/A
ROIC 22.15%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a better Operating Margin (23.27%) than 87.88% of its industry peers.
Looking at the Gross Margin, with a value of 78.16%, XPOF belongs to the top of the industry, outperforming 92.42% of the companies in the same industry.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 23.27%
PM (TTM) N/A
GM 78.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so XPOF is creating value.
Compared to 1 year ago, XPOF has more shares outstanding
XPOF has more shares outstanding than it did 5 years ago.
The debt/assets ratio for XPOF is higher compared to a year ago.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

XPOF has an Altman-Z score of -0.83. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XPOF (-0.83) is worse than 88.64% of its industry peers.
The Debt to FCF ratio of XPOF is 25.96, which is on the high side as it means it would take XPOF, 25.96 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of XPOF (25.96) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 25.96
Altman-Z -0.83
ROIC/WACC2.11
WACC10.52%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

XPOF has a Current Ratio of 1.06. This is a normal value and indicates that XPOF is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.06, XPOF perfoms like the industry average, outperforming 56.06% of the companies in the same industry.
XPOF has a Quick Ratio of 1.00. This is a normal value and indicates that XPOF is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of XPOF (1.00) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

XPOF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.53%, which is quite impressive.
Looking at the last year, XPOF shows a decrease in Revenue. The Revenue has decreased by -3.36% in the last year.
The Revenue has been growing by 19.93% on average over the past years. This is quite good.
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%950%
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-2.07%

3.2 Future

XPOF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 171.22% yearly.
Based on estimates for the next years, XPOF will show a small growth in Revenue. The Revenue will grow by 2.59% on average per year.
EPS Next Y516.5%
EPS Next 2Y249.83%
EPS Next 3Y171.22%
EPS Next 5YN/A
Revenue Next Year-4.01%
Revenue Next 2Y-0.83%
Revenue Next 3Y2.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.48, which means the current valuation is very expensive for XPOF.
XPOF's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of XPOF to the average of the S&P500 Index (25.47), we can say XPOF is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 5.84, the valuation of XPOF can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XPOF indicates a rather cheap valuation: XPOF is cheaper than 96.97% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.42, XPOF is valued rather cheaply.
Industry RankSector Rank
PE 28.48
Fwd PE 5.84
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XPOF indicates a rather cheap valuation: XPOF is cheaper than 83.33% of the companies listed in the same industry.
69.70% of the companies in the same industry are more expensive than XPOF, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.12
EV/EBITDA 6.91
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 171.22% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y249.83%
EPS Next 3Y171.22%

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (11/24/2025, 3:04:30 PM)

5.98

+0.08 (+1.36%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners74.33%
Inst Owner Change-3.84%
Ins Owners5.11%
Ins Owner Change20.83%
Market Cap292.06M
Revenue(TTM)315.73M
Net Income(TTM)-54.86M
Analysts78.75
Price Target11.32 (89.3%)
Short Float %18%
Short Ratio7.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-14.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)94.37%
Min EPS beat(2)16.62%
Max EPS beat(2)172.11%
EPS beat(4)2
Avg EPS beat(4)-44.73%
Min EPS beat(4)-219.74%
Max EPS beat(4)172.11%
EPS beat(8)2
Avg EPS beat(8)-60.28%
EPS beat(12)2
Avg EPS beat(12)-153.22%
EPS beat(16)2
Avg EPS beat(16)-143.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)0%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)2.69%
Revenue beat(8)5
Avg Revenue beat(8)-0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.8%
Revenue beat(16)13
Avg Revenue beat(16)4.72%
PT rev (1m)-10%
PT rev (3m)-10%
EPS NQ rev (1m)-49.11%
EPS NQ rev (3m)-60.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.77%
Revenue NQ rev (1m)-4.45%
Revenue NQ rev (3m)-7.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE 28.48
Fwd PE 5.84
P/S 0.93
P/FCF 21.12
P/OCF 15.87
P/B N/A
P/tB N/A
EV/EBITDA 6.91
EPS(TTM)0.21
EY3.51%
EPS(NY)1.02
Fwd EY17.12%
FCF(TTM)0.28
FCFY4.74%
OCF(TTM)0.38
OCFY6.3%
SpS6.46
BVpS-2.33
TBVpS-6.32
PEG (NY)0.06
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.44%
ROE N/A
ROCE 28.03%
ROIC 22.15%
ROICexc 26.31%
ROICexgc 227.32%
OM 23.27%
PM (TTM) N/A
GM 78.16%
FCFM 4.38%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 25.96
Debt/EBITDA 3.98
Cap/Depr 32.33%
Cap/Sales 1.45%
Interest Coverage 1.77
Cash Conversion 21%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1
Altman-Z -0.83
F-Score5
WACC10.52%
ROIC/WACC2.11
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%950%
EPS Next Y516.5%
EPS Next 2Y249.83%
EPS Next 3Y171.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-2.07%
Revenue Next Year-4.01%
Revenue Next 2Y-0.83%
Revenue Next 3Y2.59%
Revenue Next 5YN/A
EBIT growth 1Y3.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year470.54%
EBIT Next 3Y101.95%
EBIT Next 5YN/A
FCF growth 1Y-65.44%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-64.87%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%

XPONENTIAL FITNESS INC-A / XPOF FAQ

Can you provide the ChartMill fundamental rating for XPONENTIAL FITNESS INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to XPOF.


What is the valuation status of XPONENTIAL FITNESS INC-A (XPOF) stock?

ChartMill assigns a valuation rating of 7 / 10 to XPONENTIAL FITNESS INC-A (XPOF). This can be considered as Undervalued.


How profitable is XPONENTIAL FITNESS INC-A (XPOF) stock?

XPONENTIAL FITNESS INC-A (XPOF) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for XPOF stock?

The Price/Earnings (PE) ratio for XPONENTIAL FITNESS INC-A (XPOF) is 28.48 and the Price/Book (PB) ratio is -2.57.


Can you provide the expected EPS growth for XPOF stock?

The Earnings per Share (EPS) of XPONENTIAL FITNESS INC-A (XPOF) is expected to grow by 516.5% in the next year.